por John R. Fischer
, Senior Reporter | July 16, 2020
Providers with the uEXPLORER total-body PET/CT scanner can perform total-body dynamic PET scans on cancer patients to detect the presence of metastatic cancer, according to a new study.
Presented this week at the Society of Nuclear Medicine and Molecular Imaging 2020 Virtual Annual Meeting, the analysis confirms that it is possible to perform total-body kinetic modeling and parametric imaging with the system — qualities which enhance visibility and characterization of metastatic cancer and allow it to be identified. It is the first to assess total-body dynamic PET imaging of cancer with uEXPLORER.
"Conventionally, a radiotracer is commonly used to measure one physiological parameter," study author Guobao Wang, associate professor and Paul Calabresi Clinical Oncology K12 Scholar in the department of radiology at the University of California (UC), Davis, told HCB News. "For example, 18F-FDG has been mainly used for assessing glucose metabolism. With tracer kinetic modeling, total-body dynamic PET not only provides the parameter of glucose metabolism (i.e., FDG influx rate Ki that is proportional to glucose metabolic rate) but also parametric images of additional physiologically important parameters, such as the fractional blood volume (vb), glucose transport rate (K1) and potentially blood flow, potentially enabling a single-tracer multiparametric imaging method. Without this technical ability from total-body dynamic PET, multiparametric imaging would otherwise need multiple radiotracers, prolonged scan time and increased imaging cost."
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Static PET offers a simple snapshot of radiopharmaceutical concentration, while dynamic PET with tracer kinetic modeling generates parametric images that show how tissue behaves, enabling researchers to better detect lesions and assess responses of cancer patients to therapy. The lack of studies around the potential of these capabilities stems from the components of conventional PET scanners, which have a limited axial field-of-view and cannot perform simultaneous dynamic imaging of lesions widely separated in the body.
The method can be used with any radiotracer. For their study, Wang and his colleagues injected the tracer, 18F-FDG into a patient with metastatic renal cell carcinoma. The patient was then scanned on uEXPLORER. Static PET standardized uptake value (SUV) was calculated and kinetic modeling was performed for regional quantification in 16 areas of interest, including major organs and multiple metastases. The glucose influx rate was calculated and more kinetic modeling was used to create parametric images of the kinetic parameters. The kinetic data was then used to detect tumors and characterize them.